Deerland Probiotics & Enzymes Achieves Certification from Australia’s Therapeutic Goods Administration (TGA)

Globally Recognized Quality Certification Puts Deerland in Elite Class of Manufacturers

Deerland Probiotics & Enzymes, supplier of science-backed solutions for microbiome health, is pleased to announce that it is expanding its list of Good Manufacturing Practice (GMP) certifications with the addition of Australia’s Therapeutic Goods Administration (TGA) Certification at its Kennesaw, Georgia facilities. TGA certification represents that Deerland has demonstrated GMP management practices and systems in compliance with the manufacturing standards established by the Australian Government Department of Health and Ageing. With this most recent certification in Kennesaw and the existing certification renewal at the company’s Forsyth, MO facility, all of Deerland’s facilities have earned the elite status. In addition, the Denmark-based facility of Bifodan A/S, recently acquired by Deerland, has a mutual recognition agreement with Australia enabling it to produce TGA-certified products as well.

Read More

Deerland Probiotics & Enzymes Announces Acquisition of Bifodan A/S

Acquisition Gives Deerland a Larger Global Footprint

Deerland Probiotics & Enzymes, a US-based supplier of science-backed solutions for microbiome health, announced today its acquisition of Bifodan A/S. Bifodan, based in Hundested, Denmark, is a life science company specialized in developing, manufacturing and distributing unique probiotic product solutions as private label dietary supplements, medical devices and OTC drugs.

Read More

Deerland Earns Non-GMO Project Verification for Solarplast® Antioxidant Ingredient

Deerland is pleased to announce that it has earned Non-GMO Project verification for Solarplast®, the company’s branded enzyme-powered antioxidant ingredient for healthy aging and beauty from within.

Read More

Deerland Receives GRAS No-Objection Letter from FDA for Probiotic DE111®

Deerland is proud to announce that the FDA has issued a GRAS (Generally Recognized As Safe) No Objection Letter for its branded probiotic strain, Bacillus subtilis DE111®. A “Letter of No Objection” refers to the letter sent by the FDA confirming that they do not question the basis for the GRAS self-affirmation notification established and submitted by Deerland.

Read More

New Study: Prebiotic PreforPro® Shown to Positively Impact Gut Microbiota

Deerland has announced the publication of a clinical study demonstrating efficacy of the bacteriophage (phage) cocktail PreforPro® in favorably supporting the gut microbiota and systemic markers. PreforPro is patented for use as a prebiotic.

Read More

Probiotic Strain DE111® Found to Reduce Pro-Inflammatory Compound in Athletes in Clinical Study

A new study has found that athletes who consumed a probiotic daily may benefit by boosting immunity and recovery following strenuous training or play by reducing levels of tumor necrosis factor-alpha (TNF- α), a pro-inflammatory compound. The study, called Effects of Probiotic (Bacillus subtilis DE111) Supplementation on Immune Function, Hormonal Status, and Physical Performance in Division I Baseball Players was recently published in the journal Sports.

Read More

Deerland Probiotics & Enzymes Offers Plenty to Digest at SupplySide West 2018

SupplySide West is coming to the Mandalay Bay Las Vegas November 6-10, 2018, and Deerland Probiotics & Enzymes is excited to be participating.  Deerland will have two booths at the Expo Hall— Booth # 4937 as well as the former National Enzyme Company location (Booth # 5543). In addition, Deerland will offer a special presentation by John Deaton, Ph.D., vice president of science and technology, on the topic of the Role of Probiotics in Sports Nutrition.

Read More

Deerland Announces Updated Company Name and Logo

KENNESAW, GA (September 27, 2018) – Deerland Enzymes, Inc. (Deerland), a global leader in probiotics and enzymes, announced today it will now operate as Deerland Probiotics & Enzymes. The name change was made to reflect the company’s broader probiotic and enzyme expertise and commitment to innovation.

“In light of our rapid growth in the probiotic space and the recent acquisition of National Enzyme Company, we feel that now is the time to freshen up our logo and make our company name more direct, concise and reflective of our commitment to both probiotic and enzyme-based formulations & science,” said Scott Ravech, CEO.

Read More

Deerland Probiotics & Enzymes Obtains FSSC 22000 Certification

Deerland Probiotics & Enzymes has announced it has received FSSC 22000 certification as part of the company’s initiatives to be compliant with FDA’s new Food Safety Modernization Act of 2011 (FSMA). The certificate is applicable for the scope of design, development, manufacturing, packaging, testing and shipping of dietary supplements, feed supplements and other enzyme and probiotic-based formulations for human and animal consumption.

Read More

Deerland Enzymes & Probiotics Acquires National Enzyme Company

Deerland Probiotics & Enzymes announced on July 19th that the company had acquired National Enzyme Company (NEC). We believe this investment will allow us to bring even greater value to our customers and to the enzyme and probiotic industries we serve.

Read More